Operating Company Healthcare

Avania

Bilthoven, Netherlands

Formerly known as Avania (Bilthoven, Netherlands), Factory-CRO Group, Factory-CRO Group (Avania)

Global MedTech contract research organization (CRO) built for medical technology innovators, integrating regulatory strategy, clinical development, and market access/reimbursement to take products from concept to commercialization.

Focus Areas
Contract Research Organization (CRO), Medical device clinical development, Regulatory strategy

Tracked deals

4

4 tracked deals across 2021-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout · 1 addon

Avania Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Avania. 1 2021 2 2023 1 2024

Supporting Data

Recent Transactions

  • October 8, 2024
    Buyer
    Avania
    Target
    Anagram
    Location
    Catalonia, Spain
    Type
    Buyout

    Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.

  • Buyer
    Avania
    Target
    HULL ASSOCIATES LLC, Ironstone Product Development (IPD)
    Location
    United States; Canada
    Type
    Buyout

    Avania, a global MedTech contract research organization based in the Netherlands, has acquired HULL ASSOCIATES LLC (Boston) and Ironstone Product Development (IPD) (Toronto) to strengthen its engineering design, product development, regulatory, and market access capabilities across medical devices, diagnostics and related product categories. The acquisitions expand Avania's strategic expertise in market access/reimbursement, health economics, early product development, and regulatory strategy to better support MedTech innovators from development through commercialization.

  • February 7, 2023
    Buyer
    Avania
    Target
    MAXIS
    Industry
    Medical Devices
    Type
    Addon

    Avania, the Bilthoven-based MedTech-focused contract research organization (CRO), has acquired MAXIS, a medical-technology development services provider with offices in San Jose, California and Frankfurt am Main, Germany. The deal expands Avania's pre-clinical engineering, design validation, regulatory affairs, and field clinical/trial management capabilities and extends its international footprint.

  • June 22, 2021
    Buyer
    Avania
    Target
    IMARC
    Type
    Buyout

    Avania, a global medical-technology contract research organization (CRO) based in Bilthoven, Netherlands, has acquired IMARC, a Strongsville, Ohio–based medical device CRO. The acquisition expands Avania's U.S. footprint and capabilities in device clinical research (monitoring, auditing, safety, data management and training) while providing IMARC clients access to Avania's international network and enhanced services.

Related Acquisition Pages

Selling a company? Get in front of buyers like Avania

Turn tracked acquisition activity into an outreach-ready buyer list.